Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00090610
Status:
COMPLETED
Last Update Posted:
2015-02-25
First Post:
2004-08-27
Brief Title:
Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
Sponsor:
Duke University
Organization:
Duke University
Organization Data
Organization:
Duke University
Class:
OTHER
Study ID:
Pro00008381
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Duke University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Aventis Pharmaceuticals | INDUSTRY |